ScholarIQanswers from OpenAlex

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

PaperCitations, authors & open-access status

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer have?

ScholarIQcitation count

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer has 1,834 citations in the OpenAlex counts ScholarIQ stores.

When was Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer published?

ScholarIQyear

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer has 2005 year in the ScholarIQ index.

What is the open-access status of Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer?

ScholarIQoa status

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer has bronze oa status in the ScholarIQ index.

What is the DOI of Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer?

ScholarIQdoi

The DOI for Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer is on the source record.

What is the PMID of Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer?

ScholarIQpmid

The PMID for Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer is on the source record.

What is the OpenAlex record for Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer?

ScholarIQopenalex

The OpenAlex for Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial